Publications
Filters: First Letter Of Last Name is N [Clear All Filters]
“Climate induces seasonality in pneumococcal transmission”, Sci Rep, vol. 5, p. 11344, 2015.
, “Two-phase importance sampling for inference about transmission trees”, Proceedings of the Royal Society B: Biological Sciences, vol. 281, no. 1794, 2014.
, “Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?”, CNS DRUGS, vol. 11, no. 1, pp. 1-8, 1999.
, “Halofantrine in the Treatment of Malaria”, DRUG SAFETY, vol. 13, no. 4, pp. 271-272, 1995.
, “Malaria misconceptions”, Lancet, vol. 365, no. 9460, p. 653, 2005.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “Combination therapy for malaria: the way forward?”, Drugs, vol. 62, no. 9, pp. 1315-29, 2002.
, “Safety and efficacy of artemether-lumefantrine in the treatment of acute, uncomplicated falciparum malaria in adults: a pooled analysis of individual patient data”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 245.
, “Community based studies on the treatment of multi-drug resistant falciparum malaria”, in ICOPA IX - 9th International congress of parasitology, Nakasaki, Japan, 1998, pp. 523-528.
, “Antimalarial drugs in pregnancy: a review”, Current Drug Safety, vol. 1, no. 1, pp. 1-16, 2006.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Malaria in pregnancy and the endemicity spectrum: what can we learn?”, Trends in Parasitology, vol. 20, no. 9, pp. 425-432, 2004.
, “Effects of Plasmodium vivax malaria in pregnancy”, Lancet, vol. 354, no. 9178, pp. 546-9, 1999.
, “Artemisinin-Based Combination Treatment of Falciparum Malaria”, The American Journal of Tropical Medicine and Hygiene, vol. 77, no. 6 Suppl, pp. 181-192, 2007.
, “Malaria: still no vaccine and very few drugs”, Current Opinion in Infectious Diseases, vol. 9, no. 6, pp. 429-434, 1996.
, “[Malaria control in Plasmodium falciparum resistant to multi-therapy a field opinion]”, Med Trop (Mars), vol. 65, no. 1, pp. 91-2, 2005.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “[Malaria in pregnancy: a therapeutic dilemma]”, Med Sci (Paris), vol. 25, no. 10, pp. 867-9, 2009.
, “Use of artemisinin derivatives for the control of malaria”, Medecine Tropicale, vol. 58, no. 3, pp. 45-9, 1998.
, “Letters to the Editor”, The American Journal of Tropical Medicine and Hygiene, vol. 74, no. 6, p. 940, 2006.
, “Treatment of multidrug-resistant Plasmodium falciparum malaria with 3- day artesunate-mefloquine combination”, Journal of Infectious Diseases, vol. 170, no. 4, pp. 971-7, 1994.
, “The detection and treatment of Plasmodium falciparum malaria: Time for change”, Journal of Postgraduate Medicine, vol. 50, no. 1, pp. 35-9, 2004.
, “Beriberi in Cambodia”, Paediatr Int Child Health, p. 2046905515Y0000000015, 2015.
, “Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study”, Lancet, vol. 356, no. 9226, pp. 297-302, 2000.
, “Case management of malaria in pregnancy”, Lancet Infect Dis, vol. 7, no. 2, pp. 118-25, 2007.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
, “Pyronaridine-artesunate for uncomplicated falciparum malaria”, Lancet, vol. 375, no. 9724, pp. 1413-4, 2010.
, “Modes d'action et caracteristiques pharmacologiques des antipaludiques”, Medecine et Maladies Infectieuses, vol. 29, Supplement 3, pp. S307-S315, 1999.
, “We still need artesunate monotherapy”, BMJ, vol. 333, no. 7557, p. 45, 2006.
, “Artemisinin: large community studies”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88 Suppl 1, pp. S45-6, 1994.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
, “Prophylactic effect of Malarone against malaria: all good news?”, Lancet, vol. 356, no. 9245, pp. 1864-5, 2000.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective”, Malar J, vol. 14, no. 1, p. 248, 2015.
, “Waking the Sleeping Beauty”, The Journal of Infectious Diseases, vol. 202, no. 9, pp. 1300-1301, 2010.
, “The effects of mefloquine treatment in pregnancy”, Clinical Infectious Diseases, vol. 28, no. 4, pp. 808-15, 1999.
, “New antimalarials. A risk-benefit analysis”, DRUG SAFETY, vol. 12, no. 4, pp. 264-73, 1995.
, “Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study”, British Journal of Clinical Pharmacology, vol. 30, no. 1. pp. 79-85, 1990.
, “Intrarectal artemisinin derivatives”, Medecine Tropicale, vol. 58, no. 3, pp. 63-4, 1998.
, “Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 3, pp. 305-306, 1993.
, “New malaria maps”, Lancet, vol. 394, no. 10195, pp. 278-279, 2019.
, “Close kinship within multiple-genotype malaria parasite infections”, Proceedings of the Royal Society B: Biological Sciences, 2012.
, “Population genetic correlates of declining transmission in a human pathogen”, Mol Ecol, vol. 22, no. 2, pp. 273-85, 2013.
, “Genetic Evaluation of the Performance of Malaria Parasite Clearance Rate Metrics”, J Infect Dis, 2013.
, “Manslaughter by fake artesunate in Asia--will Africa be next?”, PLoS Med, vol. 3, no. 6, p. e197, 2006.
, “Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 46, no. 4, pp. 1125-7., 2002.
, “Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria”, Antimicrob Agents Chemother, vol. 49, no. 4, pp. 1622-5, 2005.
, “Correction: Manslaughter by Fake Artesunate in Asia‚ÄîWill Africa Be Next?”, PLoS Med, vol. 3, no. 8, p. e324, 2006.
, “Fake artesunate in southeast Asia”, Lancet, vol. 357, no. 9272, pp. 1948-50., 2001.
, “The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data”, PLoS Med, vol. 10, no. 12, p. e1001564, 2013.
, “The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data”, Lancet Infect Dis, vol. 15, no. 6, pp. 692-702, 2015.
, “Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice”, Med Microbiol Immunol, vol. 207, no. 5-6, pp. 271-286, 2018.
, “Selection strength and hitchhiking around two anti-malarial resistance genes”, Proc Biol Sci, vol. 272, no. 1568, pp. 1153-61, 2005.
, “Limited polymorphism of the Kelch propeller domain in P. malariae and P. ovale isolates from Thailand”, Antimicrob Agents Chemother, 2016.
, “Genetic changes during laboratory propagation: copy number At the reticulocyte-binding protein 1 locus of Plasmodium falciparum”, Mol Biochem Parasitol, vol. 172, no. 2, pp. 145-8, 2010.
, “Fitness Costs and the Rapid Spread of kelch13-C580Y Substitutions Conferring Artemisinin Resistance”, Antimicrob Agents Chemother, vol. 62, no. 9, 2018.
, “Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension”, International Journal of Parasitology, vol. 32, no. 7, pp. 852-8., 2002.
, “Single-cell genomics for dissection of complex malaria infections”, Genome research, vol. 24, no. 6, pp. 1028-1038, 2014.
, “Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites”, MOL BIOL EVOL, vol. 24, no. 2, pp. 562-73, 2007.
, “A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites”, Molecular Biology and Evolution, vol. 20, no. 9, pp. 1526-36, 2003.
, “Adaptive copy number evolution in malaria parasites”, PLOS GENET, vol. 4, no. 10, p. e1000243, 2008.
, “Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand”, Ann Trop Med Parasitol, vol. 98, no. 2, pp. 115-20, 2004.
, “Made in Europe: will artemisinin resistance emerge in French Guiana?”, Malar J, vol. 12, p. 152, 2013.
, “Does the shape of Plasmodium falciparum gametocytes have a function?”, Med Hypotheses, vol. 62, no. 4, pp. 618-9, 2004.
, “Photoallergy to quinine”, Trop Doct, vol. 35, no. 2, pp. 117-8, 2005.
, “Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy”, Trans R Soc Trop Med Hyg, vol. 97, no. 3, pp. 273-6, 2003.
,